R01 CA075115-12/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

1

Learning therapeutic lessons from metastasis suppressor proteins.

Smith SC, Theodorescu D. Smith SC, et al. Nat Rev Cancer. 2009 Apr;9(4):253-64. doi: 10.1038/nrc2594. Epub 2009 Feb 26. Nat Rev Cancer. 2009. PMID: 19242414 Free PMC article. Review.

2

Utilizing the molecular gateway: the path to personalized cancer management.

Overdevest JB, Theodorescu D, Lee JK. Overdevest JB, et al. Clin Chem. 2009 Apr;55(4):684-97. doi: 10.1373/clinchem.2008.118554. Epub 2009 Feb 26. Clin Chem. 2009. PMID: 19246616 Free PMC article. Review.

3

Pathways of metastasis suppression in bladder cancer.

Said N, Theodorescu D. Said N, et al. Cancer Metastasis Rev. 2009 Dec;28(3-4):327-33. doi: 10.1007/s10555-009-9197-4. Cancer Metastasis Rev. 2009. PMID: 20013033 Review.

4

The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target.

Smith SC, Theodorescu D. Smith SC, et al. Urol Oncol. 2009 Jan-Feb;27(1):42-7. doi: 10.1016/j.urolonc.2008.04.012. Urol Oncol. 2009. PMID: 19111797 Free PMC article. Review.

5

Prediction of muscle-invasive bladder cancer using urinary proteomics.

Schiffer E, Vlahou A, Petrolekas A, Stravodimos K, Tauber R, Geschwend JE, Neuhaus J, Stolzenburg JU, Conaway MR, Mischak H, Theodorescu D. Schiffer E, et al. Clin Cancer Res. 2009 Aug 1;15(15):4935-43. doi: 10.1158/1078-0432.CCR-09-0226. Epub 2009 Jul 14. Clin Cancer Res. 2009. PMID: 19602546

6

Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.

Wu Y, Moissoglu K, Wang H, Wang X, Frierson HF, Schwartz MA, Theodorescu D. Wu Y, et al. Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5807-12. doi: 10.1073/pnas.0810094106. Epub 2009 Mar 25. Proc Natl Acad Sci U S A. 2009. PMID: 19321744 Free PMC article.

7

Concordant gene expression signatures predict clinical outcomes of cancer patients undergoing systemic therapy.

Williams PD, Cheon S, Havaleshko DM, Jeong H, Cheng F, Theodorescu D, Lee JK. Williams PD, et al. Cancer Res. 2009 Nov 1;69(21):8302-9. doi: 10.1158/0008-5472.CAN-09-0798. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843853 Free PMC article.

8

Bladder cancer: narrowing the gap between evidence and practice.

Hussain MH, Wood DP, Bajorin DF, Bochner BH, Dreicer R, Lamm DL, O'Donnell MA, Siefker-Radtke AO, Theodorescu D, Dinney CP. Hussain MH, et al. J Clin Oncol. 2009 Dec 1;27(34):5680-4. doi: 10.1200/JCO.2009.23.6901. Epub 2009 Oct 26. J Clin Oncol. 2009. PMID: 19858384 Free PMC article. No abstract available.

9

Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases.

Moissoglu K, McRoberts KS, Meier JA, Theodorescu D, Schwartz MA. Moissoglu K, et al. Cancer Res. 2009 Apr 1;69(7):2838-44. doi: 10.1158/0008-5472.CAN-08-1397. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276387 Free PMC article.

10

Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy.

Pollard C, Nitz M, Baras A, Williams P, Moskaluk C, Theodorescu D. Pollard C, et al. Am J Pathol. 2009 Nov;175(5):1824-30. doi: 10.2353/ajpath.2009.090155. Epub 2009 Oct 8. Am J Pathol. 2009. PMID: 19815704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters